Eclosion is a unique life science platform launched in 2004 as a Public Private Partnership to build cutting edge science into transformational first-in-class therapeutics and platform technologies.

Eclosion combines the strengths of the Eclosion Foundation, a not-for–profit organization dedicated to evaluating the potential of novel innovation projects in its state-of-the art facilities, and of Eclosion2 & Cie SCPC, a private investment vehicle which invests from seed and focuses on a limited number of private companies building from the ground up making significant long term operational and financial commitments to those companies.

Eclosion is driven by an experienced management team which brings together scientific, operational and financial expertise and a successful track record of company creation, value generation and development of new therapeutics that will transform human healthcare.

As a result, Eclosion is the long-term partner for :

the researchers and entrepreneurs who seek to address patient's unmet medical needs through the application of their discoveries, and

the investors, providing a unique vehicle to support innovative industrial projects in the area of life sciences under an attractive economic model.